These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27313824)

  • 1. A Genetic Biomarker of Oxidative Stress, the Paraoxonase-1 Q192R Gene Variant, Associates with Cardiomyopathy in CKD: A Longitudinal Study.
    Dounousi E; Bouba I; Spoto B; Pappas K; Tripepi G; Georgiou I; Tselepis A; Elisaf M; Tsakiris D; Zoccali C; Siamopoulos K
    Oxid Med Cell Longev; 2016; 2016():1507270. PubMed ID: 27313824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraoxonase-1 gene Q192R polymorphism and reactive oxygen metabolites.
    Kotani K; Tsuzaki K; Sakane N
    J Int Med Res; 2012; 40(4):1513-8. PubMed ID: 22971504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase 1 (PON1) L55M and Q192R polymorphisms are not associated with chronic kidney disease in Thai individuals with type 2 diabetes.
    Nawaka N; Pansang P; Saniwa A; Chaibut N; Jeenduang N
    Int J Clin Pract; 2021 Dec; 75(12):e14982. PubMed ID: 34637171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase 1 (PON1) Q192R Gene Polymorphism and Cancer Risk: A Meta-Analysis Based on 30 Publications.
    Zhang M; Xiong H; Fang L; Lu W; Wu X; Huang ZS; Wang YQ; Cai ZM; Wu S
    Asian Pac J Cancer Prev; 2015; 16(10):4457-63. PubMed ID: 26028114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sirtuin1 gene associates with left ventricular myocardial hypertrophy and remodeling in two chronic kidney disease cohorts: a longitudinal study.
    Spoto B; Ntounousi E; Testa A; Liakopoulos V; D'Arrigo G; Tripepi G; Parlongo RM; Sanguedolce MC; Mallamaci F; Zoccali C
    J Hypertens; 2018 Aug; 36(8):1705-1711. PubMed ID: 29702498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between Paraoxonase 1 (PON1) Polymorphisms and the Risk of Acute Coronary Syndrome in a North African Population.
    Bounafaa A; Berrougui H; Ghalim N; Nasser B; Bagri A; Moujahid A; Ikhlef S; Camponova P; Yamoul N; Simo OK; Essamadi A; Khalil A
    PLoS One; 2015; 10(8):e0133719. PubMed ID: 26241956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Q192R paraoxonase 1 polymorphism and serumadipocyte-fatty acid binding protein (FABP4) levels in Mexican women.
    Ochoa-Martínez ÁC; Ruíz-Vera T; Orta-García ST; Domínguez-Cortinas G; Jiménez-Avalos JA; Pérez-Maldonado IN
    Ann Hum Biol; 2017 Jun; 44(4):389-391. PubMed ID: 27712128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p.Q192R SNP of PON1 seems not to be Associated with Carotid Atherosclerosis Risk Factors in an Asymptomatic and Normolipidemic Brazilian Population Sample.
    Scherrer DZ; Zago VH; Vieira IC; Parra ES; Panzoldo NB; Alexandre F; Secolin R; Baracat J; Quintão EC; Faria EC
    Arq Bras Cardiol; 2015 Jul; 105(1):45-52. PubMed ID: 26039660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Detection of Subclinical Uremic Cardiomyopathy Using Two-Dimensional Speckle Tracking Echocardiography.
    Hassanin N; Alkemary A
    Echocardiography; 2016 Apr; 33(4):527-36. PubMed ID: 26607049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Q192R and L55M Polymorphisms of Paraoxonase 1 Gene in Chronic Myelogenous Leukemia and Chronic Lymphocytic Leukemia.
    Tomatir AG; Pehlivan S; Sahin HH; Balci SO; Budeyri S; Pehlivan M
    Anticancer Res; 2015 Sep; 35(9):4807-12. PubMed ID: 26254371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between left ventricular global longitudinal strain, health-related quality of life and functional capacity in chronic kidney disease patients with preserved ejection fraction.
    Krishnasamy R; Hawley CM; Stanton T; Howden EJ; Beetham KS; Strand H; Leano R; Haluska BA; Coombes JS; Isbel NM
    Nephrology (Carlton); 2016 Feb; 21(2):108-15. PubMed ID: 26133896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiographic assessment of the cardio-renal connection: is left ventricular hypertrophy or diastolic function more closely correlated with estimated glomerular filtration rate in patients with cardiovascular risk factors?
    Masugata H; Senda S; Goda F; Yamagami A; Okuyama H; Kohno T; Hosomi N; Yukiiri K; Noma T; Imai M; Kiyomoto H; Nishiyama A; Kohno M
    Clin Exp Hypertens; 2010 Jan; 32(2):113-20. PubMed ID: 20374184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase-1 Q192R polymorphism and antiplatelet effects of clopidogrel in patients undergoing elective coronary stent placement.
    Trenk D; Hochholzer W; Fromm MF; Zolk O; Valina CM; Stratz C; Neumann FJ
    Circ Cardiovasc Genet; 2011 Aug; 4(4):429-36. PubMed ID: 21685174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
    Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection of subclinical left ventricular myocardial dysfunction in patients with chronic kidney disease.
    Panoulas VF; Sulemane S; Konstantinou K; Bratsas A; Elliott SJ; Dawson D; Frankel AH; Nihoyannopoulos P
    Eur Heart J Cardiovasc Imaging; 2015 May; 16(5):539-48. PubMed ID: 25428945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PON1 Q192R genotype influences clopidogrel responsiveness by relative platelet inhibition instead of on-treatment platelet reactivity.
    Li X; Zhang L; Chen X; Qu F; Li J; Ma C; Yang J; Xu B; Wang H; Xu Q; Zhang Y; Li Y; Lu C; Yin T
    Thromb Res; 2013 Oct; 132(4):444-9. PubMed ID: 23993903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of PON1 Q192R genetic polymorphism on clopidogrel efficacy and cardiovascular events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events trial and the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events.
    Paré G; Ross S; Mehta SR; Yusuf S; Anand SS; Connolly SJ; Fox KA; Eikelboom JW
    Circ Cardiovasc Genet; 2012 Apr; 5(2):250-6. PubMed ID: 22368149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting.
    Sibbing D; Koch W; Massberg S; Byrne RA; Mehilli J; Schulz S; Mayer K; Bernlochner I; Schömig A; Kastrati A
    Eur Heart J; 2011 Jul; 32(13):1605-13. PubMed ID: 21527445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm.
    Ito T; Yasue H; Yoshimura M; Nakamura S; Nakayama M; Shimasaki Y; Harada E; Mizuno Y; Kawano H; Ogawa H
    Hum Genet; 2002 Jan; 110(1):89-94. PubMed ID: 11810302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating paraoxonase-1 gene Q192R and L55M polymorphism in patients with renal cell cancer.
    Uyar OA; Kara M; Erol D; Ardicoglu A; Yuce H
    Genet Mol Res; 2011 Feb; 10(1):133-9. PubMed ID: 21308654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.